The impact of postoperative complications on survival outcomes in patients with cT3/4a gastric cancer.

Authors

null

Masanori Tokunaga

National Cancer Center Hospital East, Kashiwa, Japan

Masanori Tokunaga , Yukinori Kurokawa , Yuichiro Doki , Ryunosuke Machida , Shuji Takiguchi , Yuya Sato , Hitoshi Katai , Norimasa Fukushima , Yasunori Nishida , Haruhiko Cho , Takanobu Yamada , Masahide Kaji , Junya Fujita , Narikazu Boku , Takaki Yoshikawa , Masanori Terashima

Organizations

National Cancer Center Hospital East, Kashiwa, Japan, Department of Gastroenterological Surgery, Osaka University, Graduate School of Medicine, Suita, Japan, Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, Osaka University Graduate School of Medicine, Osaka, Japan, National Cancer Center Hospital, Tokyo, Japan, Yamagata Prefectural Central Hospital, Yamagata, Japan, Keiyukai Sapporo Hospital, Sapporo, Japan, Kanagawa Cancer Center, Yokohama, Japan, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan, Toyama Prefectural Central Hospital, Toyama, Japan, Department of Surgery, Sakai City Medical Center, Sakai, Japan, Kanagawa Cancer Center, Kanagawa, Japan, Division of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan

Research Funding

Other Government Agency

Background: Recently, the negative impact of postoperative complications on long-term survival outcomes has been reported in patients with gastric cancer. However, most are single center, retrospective studies with different definitions of postoperative complications. The objective of this study was to evaluate the impact of postoperative complications on long-term outcomes using the data of a multicenter randomized controlled trial (JCOG1001). Methods: This study included 1191 out of all 1204 patients enrolled in JCOG1001 which was aimed to confirm the superiority of bursectomy for patients with cT3/4a locally advanced gastric cancer. Complications were graded by Clavien-Dindo classification. The relationships between the grade (≥grade II or ≥grade III) or type (all or intraabdominal infectious (pancreatic fistula, anastomotic leakage, and intra-abdominal abscess.)) of complications and survival outcomes were evaluated. Results: The incidences of ≥grade II and ≥grade III all complications were 23.0% and 9.7%, and those of ≥grade II and ≥grade III intraabdominal infectious complications were 13.4% and 6.9%, respectively. The hazard ratios for overall survival (OS) of patients with ≥grade II and ≥grade III all complications and those of patients with ≥grade II and ≥grade III intraabdominal infectious complications were shown in Table. With whichever definition we adopted, postoperative complications were significantly associated with OS in both univariable and multivariable analysis. Conclusions: Postoperative complication was identified as an independent prognostic factor in patients with cT3/4a gastric cancer. Hazard ratios for overall survival by univariable and multivariable Cox proportional hazard model. Clinical trial information: UMIN000003688.

Hazard ratio [95% CI]
UnivariableMultivariable
All complications≥CD II (vs. <CD II)1.47 [1.10-1.96]1.42 [1.05-1.92]
≥CD III (vs. <CD III)1.72 [1.18-2.51]1.72 [1.17-2.52]
Intraabdominal≥CD II (vs. <CD II)1.46 [1.03-2.06]1.49 [1.04-2.15]
infectious complication≥CD III (vs. <CD III)1.64 [1.04-2.56]1.67 [1.06-2.64]

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

UMIN000003688

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4067)

DOI

10.1200/JCO.2019.37.15_suppl.4067

Abstract #

4067

Poster Bd #

172

Abstract Disclosures

Similar Abstracts

First Author: Bowon Joung

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Survival outcomes in patients with resectable gastric cancer treated with total neoadjuvant therapy.

First Author: Yun Song

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Association of intensifying supportive care with improved survival in patients with gastric cancer with malignant ascites.

First Author: John D Karalis

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

The effects of pre-existing psychiatric disorders on gastric cancer survival.

First Author: Josephine Soddano